✦ LIBER ✦

The background, discovery and clinical development of BCR-ABL inhibitors

✍ Scribed by Lambert, Gemma K.; Duhme-Klair, Anne-Kathrin; Morgan, Trevor; Ramjee, Manoj K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Pharmacokinetics of the BCR–ABL

✍ Tanaka, C; Yin, O Q P; Sethuraman, V; Smith, T; Wang, X; Grouss, K; Kantarjian, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

Allosteric inhibition enhances the effic

✍ Afsar Ali Mian, Anna Metodieva, Susanne Badura, Mamduh Khateb, Nili Ruimi, Youse 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 389 KB

Target spectrum of the BCR-ABL inhibitor

✍ Hantschel, Oliver; Rix, Uwe; Superti-Furga, Giulio 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 441 KB

Advances in the structural biology, desi

✍ Paul William Manley; Sandra W. Cowan-Jacob; Jürgen Mestan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 373 KB

The Growing Arsenal of ATP-Competitive a

✍ Hantschel, O.; Grebien, F.; Superti-Furga, G. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 446 KB

The Bcr-Abl kinase inhibitor INNO-406 in

✍ Kamitsuji, Y; Kuroda, J; Kimura, S; Toyokuni, S; Watanabe, K; Ashihara, E; Tanak 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 548 KB